Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 103.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 25,020
  • Market Cap: £87.22m
  • RiskGrade: 196

Diaceutics Overview

Diaceutics is a data analytics and implementation services company which services the global pharmaceutical industry. It has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Group currently provides services to 20 of the 30 largest global pharmaceutical companies.
Competitors: Mediclinic International , Open Orphan , Cambridge Cognition Holdings, Tristel, Sourcebio International, CareTech Holding, Trellus Health

Key Personnel

CEO: Ryan Gerard Keeling
CFO: Nick Roberts
Executive Director: Peter Keeling
Independent Non-Executive Director: Richard Charles Hindson
Independent Non-Executive Director: Michael Dennis Wort
Non-Executive Chairman: Deborah Davis
Non-Executive Dir: Graham Paterson

Contact Details

Address: First Floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park, Belfast, County Antrim, United Kingdom, BT9 6GW
Website: http://www.diaceutics.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BJQTGV64

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 109.00
52 Week Low 80.50
Volume 25,020
Shares Issued 84.68m
Market Cap £87.22m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.38% below the market average90.38% below the market average90.38% below the market average90.38% below the market average90.38% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Price Trend
40.91% above the market average40.91% above the market average40.91% above the market average40.91% above the market average40.91% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
5.32% above the market average5.32% above the market average5.32% above the market average5.32% above the market average5.32% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Diaceutics Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:20 4,501 @ 102.12p
16:03 14 @ 104.00p
16:03 2 @ 104.00p
16:03 9 @ 102.00p
16:03 9 @ 104.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page